These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 11563811)

  • 1. Glomerulonephritis for the generalist.
    Mookerje BK; Lohr JW; Jenis EH; Heffner HM
    J Med; 2001; 32(3-4):115-34. PubMed ID: 11563811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of IgM nephropathy after rituximab treatment.
    Betjes MG; Roodnat JI
    Am J Kidney Dis; 2009 Jun; 53(6):1059-62. PubMed ID: 19084309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria].
    Brandenburg V; Floege J
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():158-62. PubMed ID: 16802544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proceedings: Evolutive forms of glomerulonephritis and their prognosis].
    Humair L
    Schweiz Med Wochenschr; 1975 Dec; 105(51):1758-65. PubMed ID: 1215970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modes of clinical presentation of glomerular diseases].
    Dervaux T; Moulin B
    Rev Prat; 2003 Nov; 53(18):2013-21. PubMed ID: 15008215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerulonephritis and managing the risks of chronic renal disease.
    Singh GR
    Pediatr Clin North Am; 2009 Dec; 56(6):1363-82. PubMed ID: 19962026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical problems of glomerulonephritis today].
    Stavskaia VV
    Klin Med (Mosk); 1978 Feb; 56(2):20-6. PubMed ID: 344985
    [No Abstract]   [Full Text] [Related]  

  • 11. Kidney disease screening program in Japan: history, outcome, and perspectives.
    Imai E; Yamagata K; Iseki K; Iso H; Horio M; Mkino H; Hishida A; Matsuo S
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1360-6. PubMed ID: 17942780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial function in patients with proteinuric primary glomerulonephritis.
    Mackinnon B; Deighan CJ; Ferrell WR; Sattar N; Fox JG
    Nephron Clin Pract; 2008; 109(1):c40-7. PubMed ID: 18509248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-pathological correlation--Lebanese experience].
    El Murr T; Ghayad E
    J Med Liban; 2005; 53(4):213-9. PubMed ID: 16836024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure.
    Tomita M; Sogabe H; Nakazato S; Nakatsuji S; Noto T; Hamada K; Kawachi H; Shimizu F; Matsuo M; Mutoh S
    Nephrol Dial Transplant; 2005 Nov; 20(11):2358-67. PubMed ID: 16091375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly progressive glomerulonephritis in adult Nigerians: a report of 4 cases.
    Arije A; Thomas J; Kadiri S
    Afr J Med Med Sci; 2002 Mar; 31(1):75-7. PubMed ID: 12518936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O; Watier L; Rossert J; Stengel B;
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome in children after Henoch-Schonlein purpura nephritis.
    Butani L; Morgenstern BZ
    Clin Pediatr (Phila); 2007 Jul; 46(6):505-11. PubMed ID: 17579102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying and slowing progressive chronic renal failure.
    Curtis B; Barrett BJ; Levin A
    Can Fam Physician; 2001 Dec; 47():2512-8. PubMed ID: 11785282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early diagnosis of primary chronic glomerulonephritis in the latency stage].
    Barnick P; Wulf E; Stiller D
    Z Gesamte Inn Med; 1985 Nov; 40(22):671-3. PubMed ID: 4090561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.